Help me with assessment for hirsutism with hypothyroidism and irregular menstrual cycle
Reading File
I'll research the assessment of hirsutism alongside hypothyroidism and irregular menstrual cycles, covering clinical evaluation, investigations, and differential diagnosis.
search_medical_text
hirsutism assessment clinical evaluation Ferriman-Gallwey score causes differential diagnosis
Evaluation and Treatment of Hirsutism in Premenopausal Women
Page 5
search_medical_text
hirsutism hypothyroidism irregular menstrual cycle anovulation hormonal workup investigations
Evaluation and Treatment of Hirsutism in Premenopausal Women
Page 8
GradeResponse
GradeResponse
Here is a comprehensive assessment framework for hirsutism presenting with hypothyroidism and irregular menstrual cycle:
Assessment of Hirsutism with Hypothyroidism and Irregular Menstrual Cycle
1. Understanding the Clinical Triad
This combination — hirsutism + hypothyroidism + irregular menstrual cycles — represents a hyperandrogenic endocrine disorder picture. These three features together mandate a full endocrine workup. Hypothyroidism itself can cause anovulation and menstrual irregularity, but it must be distinguished from coexisting or independent causes of androgen excess.
2. History Taking
Menstrual History
- Age of menarche
- Cycle length, regularity, duration, flow
- Oligomenorrhea (cycles >35 days) vs. amenorrhea vs. polymenorrhea
- Infertility concerns
Hirsutism History
- Age of onset — pubertal (congenital adrenal hyperplasia, PCOS) vs. adult onset (tumor, Cushing's)
- Rate of progression — sudden onset or rapid progression raises concern for an androgen-secreting tumor
- Distribution — male-pattern (androgen-driven) vs. generalized (drug-induced, familial)
- Hair removal methods in use (may mask severity)
Hypothyroid Symptoms
- Weight gain, cold intolerance, fatigue, constipation, dry skin, hair thinning/loss, bradycardia, delayed reflexes
- Known thyroid disease, prior thyroid surgery, radioiodine therapy
- Family history of autoimmune thyroid disease
Drug History
Drugs that can cause hirsutism:
- Anabolic/androgenic steroids
- Valproic acid
- Danazol, progestins with androgenic activity
- Minoxidil, cyclosporine
Family & Ethnic Background
- Important for Ferriman-Gallwey score interpretation (see below)
- Family history of PCOS, CAH, thyroid disease
3. Physical Examination
Ferriman-Gallwey (mFG) Scoring
Assess terminal hair in 9 androgen-sensitive body areas, each scored 0–4:
| Body Area | Score 0–4 |
|---|---|
| Upper lip | |
| Chin | |
| Chest | |
| Upper abdomen | |
| Lower abdomen | |
| Upper back | |
| Lower back | |
| Upper arm | |
| Thigh |
Thresholds for hirsutism (Endocrine Society guidelines):
| Population | Hirsutism threshold |
|---|---|
| US/UK Black or White women | mFG ≥ 8 |
| Mediterranean / Hispanic / Middle Eastern | mFG ≥ 9–10 |
| South American | mFG ≥ 6 |
| Han Chinese women | mFG ≥ 2 |
| Southern Chinese women | mFG ≥ 7 |
(Evaluation and Treatment of Hirsutism in Premenopausal Women, p. 5)
Note: The mFG score does not capture sideburns or buttocks — locally high scores in those areas may not elevate the total but are still clinically relevant.
Signs of Hyperandrogenism
- Acne (comedonal, papular, nodular)
- Androgenic alopecia (male-pattern hair thinning at vertex/frontal)
- Virilization (clitoromegaly, deepening voice, increased muscle mass) → suggests severe androgen excess, possibly tumor
Signs of Associated Endocrine Disorders
| Disorder | Signs to Seek |
|---|---|
| Hypothyroidism | Dry skin, coarse hair, periorbital puffiness, goiter, bradycardia, delayed relaxation of reflexes, weight gain |
| PCOS | Central obesity, acanthosis nigricans, polycystic ovaries |
| Cushing syndrome | Central obesity, moon facies, buffalo hump, striae, easy bruising, proximal myopathy, hypertension |
| Acromegaly | Enlarged hands/feet, coarse facies, prognathism, macroglossia |
| Androgen-secreting tumor | Rapidly progressive virilization, very high androgens |
| Non-classic CAH (NCCAH) | Pubertal-onset hirsutism, family history (Ashkenazi Jewish, Hispanic, Slavic heritage at higher risk) |
4. Investigations
Step 1: Confirm and Characterize Hypothyroidism
- TSH (first-line) — elevated TSH confirms primary hypothyroidism
- Free T4 — to assess severity
- Anti-TPO antibodies — if Hashimoto's thyroiditis suspected
- Anti-thyroglobulin antibodies — if anti-TPO negative but clinical suspicion high
Hypothyroidism causes elevated TRH → elevated prolactin → anovulation and menstrual irregularity. It can also directly suppress SHBG, increasing free androgen levels and contributing to hirsutism.
Step 2: Androgen Testing
(Evaluation and Treatment of Hirsutism in Premenopausal Women, p. 8)
Preferred timing: Early morning, days 4–10 of the menstrual cycle (when ovarian follicle development is most comparable to hyperandrogenic anovulation).
| Test | When to Order | Notes |
|---|---|---|
| Serum total testosterone | All women with hirsutism + clinical signs of hyperandrogenic disorder | Best measured by mass spectrometry for accuracy |
| Serum free testosterone | Moderate/severe hirsutism with normal total T; or clinical PCOS | Most clinically sensitive single marker of androgen excess |
| SHBG | Alongside free T | Reduced SHBG (e.g., from hypothyroidism, insulin resistance, obesity) increases bioavailable androgens |
| DHEAS | If adrenal source suspected | Elevated in adrenal tumors, CAH |
| 17-hydroxyprogesterone (17-OHP) | Early morning (follicular phase) | Rule out non-classic CAH; if borderline, proceed to ACTH stimulation test |
Action thresholds:
- Total testosterone > 200 ng/dL (6.9 nmol/L) → high suspicion for androgen-secreting tumor → imaging
- Total testosterone > 150 ng/dL → DHEAS assay + pelvic/adrenal imaging
Step 3: Evaluate for PCOS
PCOS is the most common hyperandrogenic endocrine disorder associated with hirsutism. After excluding thyroid disease and other causes:
Apply Rotterdam criteria (2 of 3 required):
- Oligo/anovulation
- Clinical or biochemical hyperandrogenism
- Polycystic ovarian morphology on ultrasound
Additional tests:
- LH:FSH ratio (often elevated in PCOS, though not diagnostic)
- Fasting glucose and insulin / HOMA-IR (assess insulin resistance)
- Fasting lipid profile (metabolic syndrome screen)
- Pelvic ultrasound — polycystic ovary morphology (≥12 follicles per ovary 2–9 mm in diameter, or ovarian volume >10 mL)
Step 4: Rule Out Other Causes
| Condition | Key Tests |
|---|---|
| Non-classic CAH | Early-morning 17-OHP (follicular phase); if ≥ 2 ng/mL → ACTH stimulation test |
| Cushing syndrome | 24-hour urinary free cortisol; overnight 1 mg dexamethasone suppression test; late-night salivary cortisol |
| Hyperprolactinemia | Serum prolactin (check — hypothyroidism itself raises prolactin) |
| Androgen-secreting tumor | DHEAS, testosterone; pelvic/adrenal imaging if very high androgens or rapid virilization |
| Acromegaly | IGF-1, GH after oral glucose load (if clinically suspected) |
Summary Investigation Panel
| Category | Tests |
|---|---|
| Thyroid | TSH, Free T4, Anti-TPO |
| Androgens | Total testosterone (mass spec), free testosterone, SHBG, DHEAS |
| Adrenal | 17-OHP (early morning, follicular phase) |
| Prolactin | Serum prolactin |
| PCOS screen | LH, FSH, fasting glucose, fasting insulin, lipid panel |
| Imaging | Pelvic ultrasound (ovarian morphology) ± adrenal CT/MRI if tumor suspected |
| Cushing screen | If clinically indicated: 24h UFC or overnight DST |
5. Differential Diagnosis
| Cause | Key Features |
|---|---|
| PCOS | Most common; oligomenorrhea, biochemical hyperandrogenism, polycystic ovaries |
| Hypothyroidism | Can cause anovulation and mildly elevated free androgens (via reduced SHBG); treat the thyroid first |
| Hyperprolactinemia | Can be secondary to hypothyroidism; causes anovulation, galactorrhea |
| Non-classic CAH | Pubertal/adult onset; elevated 17-OHP; high-risk ethnic groups |
| Cushing syndrome | Central obesity, striae, hypertension, glucose intolerance |
| Androgen-secreting tumor | Rapid virilization, very high testosterone or DHEAS |
| Idiopathic hirsutism | Normal androgens, regular cycles, normal ovarian morphology |
| Drug-induced | History of valproate, steroids, or testosterone-containing products |
6. Clinical Decision Algorithm
(Adapted from Evaluation and Treatment of Hirsutism in Premenopausal Women, p. 8)
Hirsutism + Menstrual Irregularity + Hypothyroid Features
↓
Confirm/treat hypothyroidism (TSH, Free T4)
↓
Is hypothyroidism the sole explanation? → Re-assess after euthyroidism
↓ (if persists or androgens elevated)
Measure Total Testosterone (early morning, days 4–10)
↓
Total T normal Total T > 150–200 ng/dL
↓ ↓
Free T + SHBG Imaging (ovarian/adrenal)
↓ + DHEAS, 17-OHP
Mild hirsutism Rule out tumor/CAH
+ normal ovaries
= Idiopathic hirsutism
↓
17-OHP (if NCCAH risk) → ACTH stimulation if elevated
↓
LH, FSH, ultrasound → PCOS evaluation
↓
Cortisol studies if Cushing suspected
Key Clinical Pearls
- Treat hypothyroidism first — correction of hypothyroidism may restore ovulatory cycles and reduce androgen availability (by normalizing SHBG), partially resolving hirsutism without additional intervention.
- Hypothyroidism → ↑TRH → ↑prolactin → anovulation; also ↓SHBG → ↑free testosterone — two independent mechanisms contributing to the triad.
- Sudden-onset or rapidly progressive hirsutism + virilization = androgen-secreting tumor until proven otherwise.
- PCOS and hypothyroidism are not mutually exclusive — both can coexist and reinforce each other.
- Idiopathic hirsutism is a diagnosis of exclusion: normal androgens, regular cycles, normal ovarian morphology.
This is a shared conversation. Sign in to Orris to start your own chat.